Oppenheimer & CO Inc Quest Diagnostics Inc Transaction History
Oppenheimer & CO Inc
- $6.42 Billion
- Q3 2024
A detailed history of Oppenheimer & CO Inc transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Oppenheimer & CO Inc holds 45,389 shares of DGX stock, worth $6.22 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
45,389
Previous 48,322
6.07%
Holding current value
$6.22 Million
Previous $6.61 Million
5.93%
% of portfolio
0.1%
Previous 0.11%
Shares
29 transactions
Others Institutions Holding DGX
# of Institutions
924Shares Held
95.1MCall Options Held
361KPut Options Held
346K-
Vanguard Group Inc Valley Forge, PA14MShares$1.92 Billion0.04% of portfolio
-
Black Rock Inc. New York, NY10.1MShares$1.38 Billion0.03% of portfolio
-
State Street Corp Boston, MA5.26MShares$722 Million0.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.85MShares$528 Million0.07% of portfolio
-
Victory Capital Management Inc3.46MShares$475 Million0.48% of portfolio
About QUEST DIAGNOSTICS INC
- Ticker DGX
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 113,887,000
- Market Cap $15.6B
- Description
- Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...